Abstract: The present invention relates to a pharmaceutical composition for preventing and/or treating inflammatory disease, the composition comprising a pyrrolopyridine-derivative compound as an active ingredient; the compound represented by Chemical Formula 1 according to the present invention, enantiomers thereof or pharmaceutically acceptable salts thereof, which have excellent inhibitory activity against not only protein kinases but also inflammatory factors and inflammatory cytokines; therefore a pharmaceutical composition comprising the same as an active ingredient may be useful in prevention, treatment and/or improvement of inflammatory disease, in particular but not limited to inflammatory bowel disease, rheumatoid arthritis, or lupus.

Abstract: The present invention relates to a pharmaceutical composition for preventing and/or treating inflammatory disease, the composition comprising a pyrrolopyridine-derivative compound as an active ingredient; the compound represented by Chemical Formula 1 according to the present invention, enantiomers thereof or pharmaceutically acceptable salts thereof, which have excellent inhibitory activity against not only protein kinases but also inflammatory factors and inflammatory cytokines; therefore a pharmaceutical composition comprising the same as an active ingredient may be useful in prevention, treatment and/or improvement of inflammatory disease, in particular but not limited to inflammatory bowel disease, rheumatoid arthritis, or lupus.

Abstract: The present invention relates to a pharmaceutical composition for preventing and/or treating inflammatory disease, the composition comprising a pyrrolopyridine-derivative compound as an active ingredient; the compound represented by Chemical Formula 1 according to the present invention, enantiomers thereof or pharmaceutically acceptable salts thereof, which have excellent inhibitory activity against not only protein kinases but also inflammatory factors and inflammatory cytokines; therefore a pharmaceutical composition comprising the same as an active ingredient may be useful in prevention, treatment and/or improvement of inflammatory disease, in particular but not limited to inflammatory bowel disease, rheumatoid arthritis, or lupus.

Abstract: The present invention relates to a pharmaceutical composition for the prevention or treatment of cancer, comprising an anticancer drug and a pyrrolo-pyridine derivative as an active ingredient. A compound represented by Chemical Formula I according to the present invention, an isomer thereof, or a pharmaceutically acceptable salt thereof has excellent inhibitory activity against protein kinases, and thus, when used in combination with other anticancer drugs, can be effectively used in the prevention, treatment or amelioration of cancer.

Abstract: A device for reducing fuel dilution of a diesel engine may include an engine oil level sensor mounted to an oil pan for storing engine oil, to sense a level of the engine oil, a heater switch switched on by a signal of a controller, when the level of the engine oil in the oil pan is increased to a reference level or more by fuel diluted in the engine oil, and a heater connected to the heater switch in the oil pan, to evaporate the fuel diluted in the engine oil while being operated by an on state of the heater switch.

Abstract: A device for reducing fuel dilution of a diesel engine may include an engine oil level sensor mounted to an oil pan for storing engine oil, to sense a level of the engine oil, a heater switch switched on by a signal of a controller, when the level of the engine oil in the oil pan is increased to a reference level or more by fuel diluted in the engine oil, and a heater connected to the heater switch in the oil pan, to evaporate the fuel diluted in the engine oil while being operated by an on state of the heater switch.

Abstract: Disclosed herein is a composition for preventing or treating pruritic or irritant skin diseases which comprises, as a vanilloid receptor antagonist, a thiourea derivative, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof, together with a pharmaceutically acceptable carrier.

Abstract: Disclosed herein is a composition for preventing or treating pruritic or irritant skin diseases which comprises, as a vanilloid receptor antagonist, a thiourea derivative, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof, together with a pharmaceutically acceptable carrier.